✦ LIBER ✦

Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged ≥65 years with rheumatoid arthritis

✍ Scribed by Derek Weycker; Elaine B. Yu; J. Michael Woolley; Gerry Oster

Book ID: 117321684
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 733 KB
Volume: 27
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(05)00090-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Time-course of health status in patients

Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab

✍ Akihiko Ban; Masaaki Inaba; Yutaka Furumitsu; Keiji Okamoto; Kazuhiko Yukioka; H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 514 KB

The LUNDEX, a new index of drug efficacy

The LUNDEX, a new index of drug efficacy in clinical practice: Results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden

✍ Lars Erik Kristensen; Tore Saxne; Pierre Geborek 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 2 views

PMS62 DIFFERENCES IN DEMOGRAPHICS AND PR

PMS62 DIFFERENCES IN DEMOGRAPHICS AND PRE-INDEX HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TAKING ANTI-TNF BIOLOGICS DURING THE FIRST YEAR OF PERSISTENT THERAPY

✍ J Rizzo; C Gunnarsson; H Fang; C Carter; S Bolge; S Mody 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Effectiveness and safety of adalimumab i

Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)

✍ Takeuchi, Tsutomu; Tanaka, Yoshiya; Kaneko, Yuko; Tanaka, Eiichi; Hirata, Shinta 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 676 KB

Direct comparison of treatment responses

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

✍ Merete Lund Hetland; Ib Jarle Christensen; Ulrik Tarp; Lene Dreyer; Annette Hans 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Cost-effectiveness of cholesterol-loweri

Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: Results from the LIPID study

✍ Andrew M. Tonkin; Simon Eckermann; Harvey White; Denis Friedlander; Paul Glaszio 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 124 KB